Women 65 and older face significantly higher rates of cervical cancer-causing HPV infections than younger women, despite current medical guidelines that typically discontinue screening at 65. The ...

TG4050 is being evaluated in a Phase I/II clinical trial for patients with HPV-negative head and neck cancers (NCT04183166). An individualized treatment is created for each patient after they complete ...

All patients in the treatment arm remain disease-free after a minimum of 2-year follow-up in the randomized Phase I trial in resected HPV-negative locally advanced head and neck cancer – Demonstrating ...

In a head-to-head comparison, significantly improved diagnostic accuracy was seen for HPV WGS compared with ddPCR, HPV Ab, and clinical workup (Youden index, 0.99 versus 0.90, 0.83, and 0.82 ...

Summary Mass General Brigham researchers developed HPV-DeepSeek, a liquid biopsy blood test achieving 99% sensitivity for early detection of HPV-associated head and neck cancers. The test, using whole ...

A new liquid biopsy blood test could help detect cases of human papillomavirus (HPV)-associated head and neck cancers with significantly higher accuracy than currently used methods, including ...

The College of American Pathologists recently updated its evidence-based guideline recommendations for the testing of human papillomavirus in head and neck carcinomas. Guideline co-chairs William ...

Head and neck cancers have traditionally been associated with smoking and drinking, but there are more instances connected to HPV, doctors say. The HPV vaccine was made available in 2006, yet ...

Glenn Moog didn't know much about HPV cancer — until he was diagnosed with it. The 59-year-old husband, father and realtor from Worthington had a swollen lymph node on his neck that kept getting ...

The HPV vaccine has been shown to reduce the incidence of cervical cancer by 90% , and some countries around the world are on the verge of eradicating it through large-scale vaccination programs.